Dr Julie Gutman
Co-Investigator: Drug Resistance & Molecular Markers
Dr. Julie Gutman is a paediatric infectious disease specialist and medical epidemiologist who has worked with the Malaria Branch at the Centres for Disease Control and Prevention (CDC) since 2007. She completed medical school at the Sackler School of Medicine, University of Tel Aviv, paediatric internship and residency at the Children’s Hospital Los Angeles, CA, paediatric infectious disease fellowship at Emory University School of Medicine, Atlanta, GA, and a masters in clinical research at Rollins School of Public Health, Emory University, Atlanta GA. She is an adjunct professor at Emory University, in the Departments of Medicine and Global Health. She is the CDC lead for the President’s Malaria Initiative interagency working group on malaria in pregnancy and an active member of the Roll Back Malaria Working Group on Malaria in Pregnancy.
Dr. Gutman’s primary research focus is on the treatment and prevention of malaria, with a particular focus on malaria in pregnancy. She has worked on a previous study in Kenya evaluating the efficacy of intermittent preventive treatment in pregnancy (IPTp) with dihydroartemisinin-piperaquine or intermittent screening and treatment in pregnancy versus the current standard, IPTp with sulfadoxine-pyrimethamine (SP), as well as a study in Malawi evaluating IPTp with dihydroartemisinin-piperaquine versus IPTp with SP. She has also been involved in studies assessing the efficacy of IPTp with SP at varying levels of parasite resistance to SP, and assessing case management of malaria in pregnancy. She has worked on studies assessing the efficacy of various antimalarials for treatment in children in Malawi and Tanzania. Prior to this, she worked on several projects assessing the prevalence of schistosomiasis and intestinal helminths in Nigeria.